CHINA RESOURCES BOYA BIO-PHARMACEUTICAL GROUP CO.,LTD

Andere talen China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Aandelen

300294

CNE100001FF1

slotkoers Shenzhen S.E. Andere beurzen 00:00:00 09-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
34,21 ^CNY	+3,07%		+8,74%	+1,57%

23/04	China Resources Boya Bio-pharmaceutical Group Co.,Ltd rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024	CI
14/03	CR Boya Bio-Pharmaceutical's 2023 winst daalt op lagere inkomsten	MT

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	23/04
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd. Approves Cash Dividend for the Year 2023	15/04
China Resources Boya Bio-Pharmaceutical Group Co.,Ltd Proposes Cash Dividend	25/03
CR Boya Bio-Pharmaceutical's 2023 Profit Falls on Lower Revenue	14/03
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
CR Boya Bio-Pharmaceutical Signs 29.5 Million Yuan Construction Contract for Blood Products Facility	06/02
China Resources Double-Crane Pharmaceutical Co.,Ltd. completed the acqyusution 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd.	03/11
CR Boya Bio-Pharmaceutical's January-September Profit Increases	26-10-23
China Resources Boya Bio-pharmaceutical Group Co.,Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	25-10-23
China Resources Double-Crane Pharmaceutical Co.,Ltd. agreed to acquire an 89.681% stake in Guizhou Tianan Pharmaceutical Company from Jiangxi Boya Pharmaceutical Investment Co., Ltd and China Resources Boya Bio-pharmaceutical Group Co.,Ltd for CNY 260 million	28-09-23
China Resources Pharmaceutical Commercial Group Company Limited completed the acquisition of 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd..	25-09-23
China Resources Pharmaceutical Commercial Group Company Limited agreed to acquire 75% stake in Guangdong Fuda Pharmaceutical Co., Ltd. from China Resources Boya Bio-pharmaceutical Group Co., Ltd. for approximately CNY 360 million.	30-08-23
China Resources Pharmaceutical's Subsidiaries Log Increases in H1 Profits	25-08-23
China Resources Boya's H1 Attributable Profit Jumps 16.9%	22-08-23
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	21-08-23
China Resources Boya Bio-pharmaceutical Group's Q1 Profit Rises	25-04-23
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	24-04-23
China Resources Boya Bio-pharmaceutical Group Co., Ltd. Approves Cash Dividend for 2022, Payable on 28 April 2023	17-04-23
CR Boya Bio-pharmaceutical Estimates Higher Q1 Profit	11-04-23
China Resources Boya Bio-Pharmaceutical Group Co., Ltd. Proposes Dividend for the Year 2022	27-03-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen China Resources Boya Bio-pharmaceutical Group Co.,Ltd

Aandelen

300294

CNE100001FF1

Andere talen

Filters